Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Sight Sciences, Inc. - Common Stock
(NQ:
SGHT
)
4.130
-0.170 (-3.95%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 30, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Sight Sciences, Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
Sight Sciences' Cataract Surgery Tech Shows Consistent Lowering Of Eye Pressure, Medication Use
May 23, 2023
Sight Sciences Inc (NASDAQ: SGHT) published two-year results of the so-called "Romeo" study of the OMNI Surgical System.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
May 08, 2023
Via
Benzinga
Recap: Sight Sciences Q1 Earnings
May 04, 2023
Via
Benzinga
A Preview Of Sight Sciences's Earnings
March 10, 2023
Via
Benzinga
Glaucoma Is The Second Leading Cause Of Blindness Globally – Skye Bioscience Appears To Be Making Rapid Progress In The Development Of Their Candidate To Treat It
March 09, 2023
Biomed company Skye Bioscience (OTCQB: SKYE) has seen positive results in its clinical research so far and is preparing for the next stage in the development of its therapy for eye disease.
Via
Benzinga
3 Prime Healthcare Takeover Targets
February 14, 2023
These three companies are attractive targets for their potential.
Via
The Motley Fool
5 Analysts Have This to Say About Sight Sciences
October 11, 2022
Within the last quarter, Sight Sciences (NASDAQ:SGHT) has observed the following analyst ratings:
Via
Benzinga
Sight Sciences' Near-Term Upside Is Limited, Says This Analyst
October 04, 2022
Via
Benzinga
4 Analysts Have This to Say About Sight Sciences
October 04, 2022
Analysts have provided the following ratings for Sight Sciences (NASDAQ:SGHT) within the last quarter:
Via
Benzinga
Lions Gate Entertainment, DexCom, Yelp And Other Big Stocks Moving Higher On Friday
February 10, 2023
U.S. stocks traded mixed, with the Nasdaq Composite dropping around 100 points on Friday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Super Micro Computer, Rayonier Advanced Materials And Some Other Big Stocks Moving Lower On Tuesday
January 10, 2023
U.S. stocks traded slightly higher, with the Dow Jones gaining around 30 points on Tuesday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Dow Rises Over 300 Points; US Adds 223,000 Jobs In December
January 06, 2023
U.S. stocks traded higher this morning, with the Dow Jones gaining more than 300 points on Friday.
Via
Benzinga
Skye Bioscience (OTCQB: SKYE) Heads Into 2023 As A Clinical-Stage Company After Dosing Its First Human Participants
December 22, 2022
This year has been quite busy for Skye Bioscience Inc. (OTCQB: SKYE).
Via
Benzinga
Sight Sciences Posts Long-Term Safety, Effectiveness Data For Glaucoma Surgical System
August 16, 2022
Via
Benzinga
Where Sight Sciences Stands With Analysts
August 12, 2022
Sight Sciences (NASDAQ:SGHT) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Sight Sciences: Q2 Earnings Insights
August 11, 2022
Sight Sciences (NASDAQ:SGHT) reported its Q2 earnings results on Thursday, August 11, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day Session
January 06, 2023
Gainers Swvl Holdings Corp. (NASDAQ: SWVL) surged 133% to $0.3218. Swvl recently announced the commencement of a strategic review process.
Via
Benzinga
Unity Software, Amazon, Doximity And Other Big Gainers From Friday
November 14, 2022
U.S. stocks closed higher on Friday, with the Nasdaq Composite jumping more than 200 points. Here is the list of some big stocks recording gains in the previous session.
Via
Benzinga
Earnings Scheduled For August 11, 2022
August 11, 2022
Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 6, 2023
January 06, 2023
Via
Benzinga
Why Tattooed Chef Shares Dipped Around 15%; Here Are 95 Biggest Movers From Friday
November 14, 2022
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 56.6% to settle at $19.10 on Friday.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
November 11, 2022
Gainers
Via
Benzinga
Dow Turns Higher; Nasdaq Jumps Over 200 Points
November 11, 2022
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 60 points on Friday.
Via
Benzinga
Why Compass Shares Are Trading Higher By Over 56%? Here Are 63 Stocks Moving In Friday's Mid-Day Session
November 11, 2022
Gainers Snail, Inc. (NASDAQ: SNAL) shares jumped 74.9% to $3.9350 after the company announced a $5 million share repurchase program.
Via
Benzinga
Nasdaq Surges 100 Points; Crude Oil Rises Sharply
November 11, 2022
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining 100 points on Friday.
Via
Benzinga
US Stocks Mixed Following Thursday's Rally; Dow Drops 50 Points
November 11, 2022
U.S. stocks traded mixed this morning on Friday, after the Dow Jones jumped 1,200 points in the previous session.
Via
Benzinga
Earnings Scheduled For November 10, 2022
November 10, 2022
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report earnings for its third quarter.
Via
Benzinga
Morgan Stanley Maintains Overweight Rating for Sight Sciences: Here's What You Need To Know
October 11, 2022
Morgan Stanley has decided to maintain its Overweight rating of Sight Sciences (NASDAQ:SGHT) and lower its price target from $14.00 to $10.00. Shares of Sight Sciences are trading down 3.39% over the...
Via
Benzinga
Expert Ratings for Sight Sciences
October 04, 2022
Over the past 3 months, 4 analysts have published their opinion on Sight Sciences (NASDAQ:SGHT) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
Sight Sciences's Return On Capital Employed Insights
September 07, 2022
Sight Sciences (NASDAQ:SGHT) brought in sales totaling $17.23 million during Q2 according to data provided by Benzinga Pro. However, earnings decreased 2.49%, resulting in a loss of $23.84 million.
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.